Penlabs Division of Bachem
Since the early 1970's, both companies have served the life-science communities by supplying the highest quality products immediately available from stock. Our combined forces will be mutually beneficial to each organization and to thousands of customers dependent on our products for their research. Our dedication to life sciences produces an average of several new products introduced to the marketplace every day of the year.
Both Bachem and Peninsula manufacture active drug substances and diagnostics in bulk under cGMP. We are experts in producing bulk synthetic peptides as active drug substances for clinical applications, and are the licensed commercial manufacturer of bulk peptide intermediates for many approved products world-wide. Core competencies of the Bachem group include documented regulatory compliance, regulatory support for our customers, and FDA submissions.
In addition, we have scalable manufacturing capabilities for organics, custom synthetic peptides, and immunology products. Please contact us for consultations and quotations.
On this occasion we want to thank all of our customers for their support over the years.
For over twenty-five years, Peninsula Laboratories, Inc. (PLI, PenLabs, Pen Labs) has provided synthetic peptides to life scientists worldwide. For the convenience of this research community, over 6000 biologically active synthetic peptides, peptide antibodies, immunoassay kits, enzyme substrates, and other synthetic chemicals are listed and can be purchased on this web site. Our Quality Control department performs a battery of tests to confirm purity levels, and we provide amino acid analysis and HPLC results from two systems with every custom peptide.